Clinical Trial Update: Phase I Study of TSN084 in Patients With Advanced Malignant Tumors. [Phase 1]

View source ↗

Summary

A Phase I clinical trial of TSN084 in patients with advanced malignant tumors is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TSN084

Snippet

Sponsor: Tyligand Bioscience (Shanghai) Limited | Conditions: Cancer (With or Without Metastasis) | Phase 1 | Status: ACTIVE_NOT_RECRUITING